Wednesday Aug 20
Pharma shares buck stock market trend, lead gainers
Drug makers rise, bucking the stock market trend as investors seek defensives. Ranbaxy Laboratories is up 4 percent, while Sun Pharmaceutical Industries gains 4.2 percent after marking an all-time high of 839 rupees.
Sun bid to address monopoly concern
Mumbai, Aug. 13: Sun Pharma today said it was in discussion with the Competition Commission of India to allay apprehensions about the impact of its acquisition of Ranbaxy Laboratories on the domestic pharmaceutical sector.
The Indian Express
Sun Pharma-Ranbaxy Lab deal comes under CCI scanner
Competition Commission of India would take a final view on the deal after receiving details from them and could seek more information if it is not satisfied with the responses.
Ranbaxy Laboratories 1QFY2015 performance highlights and results update
For 1QFY2015, Ranbaxy Laboratories posted a lower-than-expected set of results. For the period, sales came in at Rs.2,372cr V/s Rs.2,633cr in 2QFY2014, ie a yoy de-growth of 9.9%.
Sun Pharma to seek shareholders nod for Ranbaxy acquisition
Mumbai-based Sun Pharmaceutical Industries will seek shareholders nod for its $4 billion acquisition of Ranbaxy Laboratories in a court convened meeting on August 22. In a filing to the BSE, the company said the meeting would be held at Vadodara on August 22, 2014.